IBDEI1R6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29758,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29758,1,1,0)
 ;;=1^36593
 ;;^UTILITY(U,$J,358.3,29758,1,3,0)
 ;;=3^Declot Vascular Device
 ;;^UTILITY(U,$J,358.3,29759,0)
 ;;=S9445^^116^1482^32^^^^1
 ;;^UTILITY(U,$J,358.3,29759,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29759,1,1,0)
 ;;=1^S9445
 ;;^UTILITY(U,$J,358.3,29759,1,3,0)
 ;;=3^Pt Education NOC Ind
 ;;^UTILITY(U,$J,358.3,29760,0)
 ;;=77399^^116^1482^30^^^^1
 ;;^UTILITY(U,$J,358.3,29760,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29760,1,1,0)
 ;;=1^77399
 ;;^UTILITY(U,$J,358.3,29760,1,3,0)
 ;;=3^Medical Radiation Physics,Dosimetry
 ;;^UTILITY(U,$J,358.3,29761,0)
 ;;=J9000^^116^1483^35^^^^1
 ;;^UTILITY(U,$J,358.3,29761,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29761,1,1,0)
 ;;=1^J9000
 ;;^UTILITY(U,$J,358.3,29761,1,3,0)
 ;;=3^Doxorubicin Inj 10mg
 ;;^UTILITY(U,$J,358.3,29762,0)
 ;;=J9031^^116^1483^9^^^^1
 ;;^UTILITY(U,$J,358.3,29762,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29762,1,1,0)
 ;;=1^J9031
 ;;^UTILITY(U,$J,358.3,29762,1,3,0)
 ;;=3^BCG (Intravesical)
 ;;^UTILITY(U,$J,358.3,29763,0)
 ;;=J9040^^116^1483^13^^^^1
 ;;^UTILITY(U,$J,358.3,29763,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29763,1,1,0)
 ;;=1^J9040
 ;;^UTILITY(U,$J,358.3,29763,1,3,0)
 ;;=3^Bleomycin Sulfate Inj 15U
 ;;^UTILITY(U,$J,358.3,29764,0)
 ;;=J9045^^116^1483^16^^^^1
 ;;^UTILITY(U,$J,358.3,29764,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29764,1,1,0)
 ;;=1^J9045
 ;;^UTILITY(U,$J,358.3,29764,1,3,0)
 ;;=3^Carboplatin Inj 50mg
 ;;^UTILITY(U,$J,358.3,29765,0)
 ;;=J9060^^116^1483^19^^^^1
 ;;^UTILITY(U,$J,358.3,29765,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29765,1,1,0)
 ;;=1^J9060
 ;;^UTILITY(U,$J,358.3,29765,1,3,0)
 ;;=3^Cisplatin Inj 10mg
 ;;^UTILITY(U,$J,358.3,29766,0)
 ;;=J9100^^116^1483^23^^^^1
 ;;^UTILITY(U,$J,358.3,29766,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29766,1,1,0)
 ;;=1^J9100
 ;;^UTILITY(U,$J,358.3,29766,1,3,0)
 ;;=3^Cytarabine (arac) Inj 100mg
 ;;^UTILITY(U,$J,358.3,29767,0)
 ;;=J9181^^116^1483^38^^^^1
 ;;^UTILITY(U,$J,358.3,29767,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29767,1,1,0)
 ;;=1^J9181
 ;;^UTILITY(U,$J,358.3,29767,1,3,0)
 ;;=3^Etoposide (VP 16) Inj 10mg
 ;;^UTILITY(U,$J,358.3,29768,0)
 ;;=J9185^^116^1483^40^^^^1
 ;;^UTILITY(U,$J,358.3,29768,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29768,1,1,0)
 ;;=1^J9185
 ;;^UTILITY(U,$J,358.3,29768,1,3,0)
 ;;=3^Fludarabine Inj 50mg
 ;;^UTILITY(U,$J,358.3,29769,0)
 ;;=J9190^^116^1483^41^^^^1
 ;;^UTILITY(U,$J,358.3,29769,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29769,1,1,0)
 ;;=1^J9190
 ;;^UTILITY(U,$J,358.3,29769,1,3,0)
 ;;=3^Fluorouracil Inj 500mg
 ;;^UTILITY(U,$J,358.3,29770,0)
 ;;=J9201^^116^1483^43^^^^1
 ;;^UTILITY(U,$J,358.3,29770,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29770,1,1,0)
 ;;=1^J9201
 ;;^UTILITY(U,$J,358.3,29770,1,3,0)
 ;;=3^Gemcitabine Inj 200mg
 ;;^UTILITY(U,$J,358.3,29771,0)
 ;;=J9202^^116^1483^44^^^^1
 ;;^UTILITY(U,$J,358.3,29771,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29771,1,1,0)
 ;;=1^J9202
 ;;^UTILITY(U,$J,358.3,29771,1,3,0)
 ;;=3^Goserelin Inj per 3.6mg
 ;;^UTILITY(U,$J,358.3,29772,0)
 ;;=J9206^^116^1483^15^^^^1
 ;;^UTILITY(U,$J,358.3,29772,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29772,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,29772,1,3,0)
 ;;=3^Camptosar Inj 20mg
 ;;^UTILITY(U,$J,358.3,29773,0)
 ;;=J9208^^116^1483^48^^^^1
 ;;^UTILITY(U,$J,358.3,29773,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29773,1,1,0)
 ;;=1^J9208
 ;;^UTILITY(U,$J,358.3,29773,1,3,0)
 ;;=3^Ifosfamide (IFEX) Inj 1gr
 ;;^UTILITY(U,$J,358.3,29774,0)
 ;;=J9209^^116^1483^61^^^^1
